Literature DB >> 17426455

Macrophage migration inhibitory factor coordinates DNA damage response with the proteasomal control of the cell cycle.

Alice Nemajerova1, Ute M Moll, Oleksi Petrenko, Günter Fingerle-Rowson.   

Abstract

Proper repair of DNA damage is critical for protecting genomic stability, cellular viability and suppression of tumorigenesis. Both p53-dependent and p53-independent pathways have evolved to coordinate the cellular response following DNA damage. In this review, we highlight the importance of the ubiquitously expressed protein macrophage migration inhibitory factor (MIF) for an appropriate response to DNA damage. We discuss the mechanisms by which MIF affects the activity of the ubiquitin-proteasome system, and how this impacts on the integrity of the genome and on cancer.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17426455     DOI： 10.4161/cc.6.9.4163

Source DB:  PubMed          Journal:  Cell Cycle        ISSN： 1551-4005            Impact factor:   4.534


  14 in total

1.  Loss of macrophage migration inhibitory factor impairs the growth properties of human HeLa cervical cancer cells.

Authors:  D Z Xiao; B Dai; J Chen; Q Luo; X Y Liu; Q X Lin; X H Li; W Huang; X Y Yu
Journal:  Cell Prolif       Date:  2011-10-13       Impact factor: 6.831

2.  Plasmodium yoelii macrophage migration inhibitory factor is necessary for efficient liver-stage development.

Authors:  Jessica L Miller; Anke Harupa; Stefan H I Kappe; Sebastian A Mikolajczak
Journal:  Infect Immun       Date:  2012-01-17       Impact factor: 3.441

3.  A tautomerase-null macrophage migration-inhibitory factor (MIF) gene knock-in mouse model reveals that protein interactions and not enzymatic activity mediate MIF-dependent growth regulation.

Authors:  Günter Fingerle-Rowson; Dayananda Rao Kaleswarapu; Corinna Schlander; Nazanin Kabgani; Tania Brocks; Nina Reinart; Raymonde Busch; Anke Schütz; Hongqi Lue; Xin Du; Aihua Liu; Huabao Xiong; Yibang Chen; Alice Nemajerova; Michael Hallek; Jürgen Bernhagen; Lin Leng; Richard Bucala
Journal:  Mol Cell Biol       Date:  2009-02-02       Impact factor: 4.272

4.  COP9 signalosome interacts ATP-dependently with p97/valosin-containing protein (VCP) and controls the ubiquitination status of proteins bound to p97/VCP.

Authors:  Sevil Cayli; Jörg Klug; Julius Chapiro; Suada Fröhlich; Gabriela Krasteva; Lukas Orel; Andreas Meinhardt
Journal:  J Biol Chem       Date:  2009-10-13       Impact factor: 5.157

5.  Involvement of CD74 in head and neck squamous cell carcinomas.

Authors:  Nadège Kindt; Jérôme R Lechien; Denis Nonclercq; Guy Laurent; Sven Saussez
Journal:  J Cancer Res Clin Oncol       Date:  2014-03-25       Impact factor: 4.553

6.  Macrophage migration inhibitory factor promotes colorectal cancer.

Authors:  Xing-Xiang He; Ken Chen; Jun Yang; Xiao-Yu Li; Huo-Ye Gan; Cheng-Yong Liu; Thomas R Coleman; Yousef Al-Abed
Journal:  Mol Med       Date:  2008-11-10       Impact factor: 6.354

7.  Brain miffed by macrophage migration inhibitory factor.

Authors:  Nic E Savaskan; Günter Fingerle-Rowson; Michael Buchfelder; Ilker Y Eyüpoglu
Journal:  Int J Cell Biol       Date:  2012-09-03

8.  Spatiotemporal patterns of macrophage migration inhibitory factor (Mif) expression in the mouse placenta.

Authors:  Miriam R Faria; Mara S Hoshida; Eloisa Av Ferro; Francesca Ietta; Luana Paulesu; Estela Bevilacqua
Journal:  Reprod Biol Endocrinol       Date:  2010-08-04       Impact factor: 5.211

9.  Macrophage migration inhibitory factor produced by the tumour stroma but not by tumour cells regulates angiogenesis in the B16-F10 melanoma model.

Authors:  E Girard; C Strathdee; E Trueblood; C Quéva
Journal:  Br J Cancer       Date:  2012-09-06       Impact factor: 7.640

10.  HSP90 inhibitor antagonizing MIF: The specifics of pleiotropic cancer drug candidates.

Authors:  Ramona Schulz; Matthias Dobbelstein; Ute M Moll
Journal:  Oncoimmunology       Date:  2012-11-01       Impact factor: 8.110
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.